Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20000082HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20007360HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20027601HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20027588HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20015105HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20019576HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20019577HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20030913HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS44013030HTLV-1ENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TCGA Plot Options
Drug Information
GeneFGFR3
DrugBank IDDB15102
Drug NamePemigatinib
Target IDBE0002133
UniProt IDP22607
Regulation Typeinhibitor
PubMed IDs32315352
CitationsLiu PCC, Koblish H, Wu L, Bowman K, Diamond S, DiMatteo D, Zhang Y, Hansbury M, Rupar M, Wen X, Collier P, Feldman P, Klabe R, Burke KA, Soloviev M, Gardiner C, He X, Volgina A, Covington M, Ruggeri B, Wynn R, Burn TC, Scherle P, Yeleswaram S, Yao W, Huber R, Hollis G: INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models. PLoS One. 2020 Apr 21;15(4):e0231877. doi: 10.1371/journal.pone.0231877. eCollection 2020.
GroupsApproved; Investigational
Direct Classification
SMILESCCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F
Pathways
PharmGKB
ChEMBLCHEMBL4297522